These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3384939

  • 1. Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Fuchs PC, Barry AL, Jones RN.
    J Clin Microbiol; 1988 Jun; 26(6):1246-7. PubMed ID: 3384939
    [Abstract] [Full Text] [Related]

  • 2. [Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
    Villar HE, Jugo MB, Fernández-Lausi A, Farinati AE.
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):308-10. PubMed ID: 8744371
    [Abstract] [Full Text] [Related]

  • 3. Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.
    Jones RN, Barry AL.
    J Clin Microbiol; 1987 Oct; 25(10):1920-5. PubMed ID: 3117843
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors.
    Carsenti-Etesse H, Durant J, De Salvador F, Bensoussan M, Bensoussan F, Pradier C, Bernard E, Mondain V, Thabaut A, Dellamonica P.
    Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1058-62. PubMed ID: 7889969
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.
    Fuchs PC, Barry AL, Pfaller MA, Hardy DJ, McLaughlin JC, Gerlach EH.
    Diagn Microbiol Infect Dis; 1993 Dec; 17(2):171-5. PubMed ID: 8243040
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections.
    Gisby J, Beale AS.
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1830-3. PubMed ID: 3072924
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D, Simonet M, Veron M.
    Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362
    [Abstract] [Full Text] [Related]

  • 12. Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
    Pfaller M, Barry A, Fuchs P, Gerlach E, Hardy D, McLaughlin J.
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):200-5. PubMed ID: 8389705
    [Abstract] [Full Text] [Related]

  • 13. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
    Fuchs PC, Barry AL.
    J Clin Microbiol; 1994 Nov; 32(11):2846-50. PubMed ID: 7852584
    [Abstract] [Full Text] [Related]

  • 14. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A, Roudon T.
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [Abstract] [Full Text] [Related]

  • 15. Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
    Citron DM, Goldstein EJ, Kenner MA, Burnham LB, Inderlied CB.
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S356-60. PubMed ID: 7548597
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ, Ponticas S, Shungu DL, Guerriero S.
    Clin Ther; 1991 Jun; 13(1):25-37. PubMed ID: 2029725
    [Abstract] [Full Text] [Related]

  • 18. Association experiments in antimicrobial susceptibility testing of aerobes and anaerobes to ampicillin and ampicillin plus sulbactam.
    Heizmann WR, Werner H, Heilmann F.
    J Chemother; 1989 Jul; 1(4 Suppl):315-6. PubMed ID: 16312418
    [No Abstract] [Full Text] [Related]

  • 19. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S, Marre R.
    Infection; 1991 Jul; 19(2):106-9. PubMed ID: 1646771
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
    Muñoz Bellido JL, Muñoz Criado S, García García I, Alonso Manzanares MA, Gutiérrez Zufiaurre MN, García-Rodríguez JA.
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.